Previous 10 | Next 10 |
home / stock / bayzf / bayzf news
Inflation and the better than feared earnings season dominate market movements. Markets remain very volatile following record inflation readings paired with an aggressive Fed and negative consumer sentiment. Inflation is softening in July and markets have started to rally again. U...
BeiGene ( NASDAQ: BGNE ) and Novartis' ( NYSE: NVS ) tislelizumab met the main goal of being as good as Bayer's ( OTCPK:BAYZF ) ( OTCPK:BAYRY ) Nexavar (sorafenib) in improving overall survival (OS) of patients with a type of liver cancer in a phase 3 trial...
This month I had a total of 11 transactions. I sold my positions in Power REIT and Reinsurance Group of America. I reached over €1,000 in forward dividends. In contrast to the first half a year of 2022, July was a good month when it comes to stock returns. July wa...
Hutchmed (China) ( NASDAQ: HCM ) said its medicine fruquintinib met the main goal of overall survival (OS) in patients with advanced, refractory metastatic colorectal cancer (CRC) in a phase 3 trial. The study called FRESCO-2 evaluated fruquintinib plus be...
In Q2 2022, Bayer delivered strong results across all of the company's divisions. Bayer generated revenues of EUR 12.8 billion (+9.6% year over year), and EBITDA before special items jumped by more than 30% to EUR 3.3 billion. Bayer also guided an improved FY 2022 outlook and high...
Bayer Aktiengesellschaft (BAYZF) Q2 2022 Results Conference Call August 04, 2022 09:00 AM ET Company Participants Oliver Maier - Head, IR Werner Baumann - CEO Wolfgang Nickl - CFO Rodrigo Santos - Head, Crop Science Stefan Oelrich - Head, Pharmaceuticals ...
The following slide deck was published by Bayer Aktiengesellschaft in conjunction with their 2022 Q2 earnings call. For further details see: Bayer Aktiengesellschaft 2022 Q2 - Results - Earnings Call Presentation
Bayer's ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) Q2 sales grew on the back of Crop Science and Consumer Health businesses, while the company also raised its FY22 outlook. The German conglomerate's core EPS grew +19.9% Y/Y to €1.93. EBITDA before special items increase...
Bayer AG press release ( OTCPK:BAYZF ): Q2 Non-GAAP EPS of €1.93. Revenue of €12.82B (+18.2% Y/Y). EBITDA before special items rises to €3.3B (+ 30.0%). Free cash flow of €1.1B. For fiscal 2022, we now expect to generate currency-adjuste...
ABMD , ABUS , ACIW , ADAP , OTCQX:ADDYY , ADT , AG , AGIO , AHH , APD , APO , APTV , ARW , ATI , AUPH , AUTL , AZEK , BABA , BALL , BALY , OTCPK:BAYZF , BCE , BCRX , BDX , BKI , CBRE , ...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG Registered Shares Company Name:
BAYZF Stock Symbol:
OTCMKTS Market:
NORTHAMPTON, MA / ACCESSWIRE / August 29, 2023 / Bayer - As climate change quickens, societal expectations increase and the threat of resistance grows, new crop protection solutions are imperative. Advances in the life sciences and data-driven technologies hold the key to expanding our pipeline ...
Monsanto Must Face Georgia State Jurors in Lawsuit Over Cancer-Causing Roundup Herbicide PR Newswire 11th Circuit opinion finds chemical giant subject to state's warning label laws Nachawati Law Group trial lawyers gearing up for next Roundup cancer trial in Au...
Bayer Runs Out of Appeals at US Supreme Court as Thousands of Cancer Lawsuits Await over Roundup Herbicide PR Newswire Fears Nachawati trial lawyers gearing up for next Roundup cancer trial in August WASHINGTON , June 22, 2022 /PRNewswire/ -- Baye...